SCHEMBL29390

SCHEMBL29390

C=Cc1[nH]cc[n+]1CCCC

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
RGS12 O14924 1/20 0.30
NPC1 O15118 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
HSP90AA1 P07900 1/20 0.30
THRB P10828 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
RAD52 P43351 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
MCL1 Q07820 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL12500813 0.98 ALDH1A1 (0.31) ALDH1A1TSHR
Hydrochloric Acid SCHEMBL29697222 0.98 ALDH1A1 (0.31) ALDH1A1TSHR
SCHEMBL15657208 0.93 KMT2A (0.39) ALDH1A1TSHRKDM4EMEN1RGS12
SCHEMBL9067234 0.93 KMT2A (0.39) ALDH1A1TSHRKDM4EMEN1RGS12
Bromide SCHEMBL3419365 0.91 HTT (0.38) ALDH1A1TSHRKDM4EMEN1RGS12
Bromide SCHEMBL3418571 0.91 HTT (0.38) ALDH1A1TSHRKDM4EMEN1RGS12
Iodide SCHEMBL810561 0.91 HTT (0.41) ALDH1A1TSHRKDM4EMEN1RGS12
Hydrochloric Acid SCHEMBL3419607 0.91 SMN1; SMN2 (0.38) ALDH1A1TSHRKDM4EMEN1RGS12
Hydrochloric Acid SCHEMBL8415719 0.91 SMN1; SMN2 (0.38) ALDH1A1TSHRKDM4EMEN1RGS12
Sulfuric Acid SCHEMBL30240028 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3459975-B1 POLYMERIC ACID CATALYSTS AND USES THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2024-10-02 EP claimed
WO-2022252533-A1 METAL-ORGANIC FRAMEWORK-BASED MATERIAL OF IN-PORE CONFINED POLYMERIZATION ORGANIC MONOMER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 广东工业大学 2022-12-08 WO claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
WO-2025128460-A1 ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF WILLIAMS RICHARD KENT (US) 2025-06-19 WO disclosed
CN-113056488-B Oligosaccharide compositions and methods of use thereof for reducing ammonia levels DSM营养产品有限责任公司 2023-10-24 CN disclosed
CN-110172031-B Anionic N-substituted aniline ionic liquid and preparation method thereof 北京师范大学 2021-03-16 CN disclosed
WO-2012027242-A1 HIGH FLUX MICROFILTRATION MEMBRANES WITH VIRUS AND METAL ION ADSORPTION CAPABILITY FOR LIQUID PURIFICATION THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof MYOC, MB, MYOF ALDH1A1 4755/4885TSHR 1922/4885KDM4E 3825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.